| First Author | Tang H | Year | 2016 |
| Journal | Cancer Cell | Volume | 29 |
| Issue | 3 | Pages | 285-96 |
| PubMed ID | 26977880 | Mgi Jnum | J:231765 |
| Mgi Id | MGI:5774903 | Doi | 10.1016/j.ccell.2016.02.004 |
| Citation | Tang H, et al. (2016) Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade. Cancer Cell 29(3):285-96 |
| abstractText | Immune checkpoint blockade therapies fail to induce responses in the majority of cancer patients, so how to increase the objective response rate becomes an urgent challenge. Here, we demonstrate that sufficient T cell infiltration in tumor tissues is a prerequisite for response to PD-L1 blockade. Targeting tumors with tumor necrosis factor superfamily member LIGHT activates lymphotoxin beta-receptor signaling, leading to the production of chemokines that recruit massive numbers of T cells. Furthermore, targeting non-T cell-inflamed tumor tissues by antibody-guided LIGHT creates a T cell-inflamed microenvironment and overcomes tumor resistance to checkpoint blockade. Our data indicate that targeting LIGHT might be a potent strategy to increase the responses to checkpoint blockades and other immunotherapies in non-T cell-inflamed tumors. |
